We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IFF icon
1051
International Flavors & Fragrances
IFF
$19.5B
– –
-14,662
Closed -$1.4M
IMAX icon
1052
IMAX
IMAX
$2.47B
– –
-22,810
Closed -$383K
IPAR icon
1053
Interparfums
IPAR
$3.99B
– –
-3,661
Closed -$425K
IQV icon
1054
IQVIA
IQV
$35.6B
– –
-1,865
Closed -$394K
ITW icon
1055
Illinois Tool Works
ITW
$81.9B
– –
-7,366
Closed -$1.75M
JBI icon
1056
Janus International
JBI
$732M
– –
-29,137
Closed -$368K
JBL icon
1057
Jabil
JBL
$32.6B
– –
-11,568
Closed -$1.26M
JEF icon
1058
Jefferies Financial Group
JEF
$13B
– –
-28,663
Closed -$1.43M
JPM icon
1059
JPMorgan Chase
JPM
$947B
– –
-3,475
Closed -$703K
KALU icon
1060
Kaiser Aluminum
KALU
$2.65B
– –
-2,843
Closed -$250K
KD icon
1061
Kyndryl
KD
$2.81B
– –
-13,509
Closed -$355K
KEX icon
1062
Kirby Corp
KEX
$7.76B
– –
-8,130
Closed -$973K
KLIC icon
1063
Kulicke & Soffa
KLIC
$5.14B
– –
-8,798
Closed -$433K
KMB icon
1064
Kimberly-Clark
KMB
$37B
– –
-7,656
Closed -$1.06M
KMI icon
1065
Kinder Morgan
KMI
$70.6B
– –
-26,412
Closed -$525K
KNX icon
1066
Knight Transportation
KNX
$11.5B
– –
-11,053
Closed -$552K
KO icon
1067
Coca-Cola
KO
$362B
– –
-44,284
Closed -$2.82M
MZTI
1068
The Marzetti Company
MZTI
$2.95B
– –
-7,957
Closed -$1.5M
LBTYA icon
1069
Liberty Global Class A
LBTYA
$3.35B
– –
-16,008
Closed -$279K
LBRT icon
1070
Liberty Energy
LBRT
$2.75B
– –
-49,916
Closed -$1.04M
LDOS icon
1071
Leidos
LDOS
$14.5B
– –
-11,082
Closed -$1.62M
LECO icon
1072
Lincoln Electric
LECO
$14.1B
– –
-5,932
Closed -$1.12M
LGIH icon
1073
LGI Homes
LGIH
$1.4B
– –
-10,561
Closed -$945K
LMT icon
1074
Lockheed Martin
LMT
$134B
– –
-4,020
Closed -$1.88M
LNC icon
1075
Lincoln National
LNC
$7.88B
– –
-27,337
Closed -$850K
41 42
43
44 45

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.